REPORT ID 5140

EMEA (Europe, Middle East and Africa) Animal Drugs Market Report 2017

Publish Date
20-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the EMEA Animal Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Animal Drugs for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Animal Drugs market competition by top manufacturers/players, with Animal Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Zoetis
    Boehringer Ingelheim
    Bayer
    Elanco Animal Health
    Ceva
    Dechra
    Merck
    Virbac
    Vetoquinol

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Anti-infective
    Anti-inflammatory
    Parasiticides

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Animal Drugs for each application, including
    Livestock
    Companion

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Animal Drugs Market Report 2017
1 Animal Drugs Overview
    1.1 Product Overview and Scope of Animal Drugs
    1.2 Classification of Animal Drugs
        1.2.1 EMEA Animal Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Animal Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Anti-infective
        1.2.4 Anti-inflammatory
        1.2.5 Parasiticides
    1.3 EMEA Animal Drugs Market by Application/End Users
        1.3.1 EMEA Animal Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Livestock
        1.3.3 Companion
    1.4 EMEA Animal Drugs Market by Region
        1.4.1 EMEA Animal Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Animal Drugs (2012-2022)
        1.5.1 EMEA Animal Drugs Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Animal Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Animal Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Animal Drugs Market Competition by Players/Manufacturers
        2.1.1 EMEA Animal Drugs Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Animal Drugs Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Animal Drugs Sale Price by Players (2012-2017)
    2.2 EMEA Animal Drugs (Volume and Value) by Type/Product Category
        2.2.1 EMEA Animal Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Animal Drugs Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Animal Drugs Sale Price by Type (2012-2017)
    2.3 EMEA Animal Drugs (Volume) by Application
    2.4 EMEA Animal Drugs (Volume and Value) by Region
        2.4.1 EMEA Animal Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Animal Drugs Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Animal Drugs Sales Price by Region (2012-2017)

3 Europe Animal Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Animal Drugs Sales and Value (2012-2017)
        3.1.1 Europe Animal Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Animal Drugs Revenue and Growth Rate (2012-2017)
    3.2 Europe Animal Drugs Sales and Market Share by Type
    3.3 Europe Animal Drugs Sales and Market Share by Application
    3.4 Europe Animal Drugs Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Animal Drugs Sales Volume by Countries (2012-2017)
        3.4.2 Europe Animal Drugs Revenue by Countries (2012-2017)
        3.4.3 Germany Animal Drugs Sales and Growth Rate (2012-2017)
        3.4.4 France Animal Drugs Sales and Growth Rate (2012-2017)
        3.4.5 UK Animal Drugs Sales and Growth Rate (2012-2017)
        3.4.6 Russia Animal Drugs Sales and Growth Rate (2012-2017)
        3.4.7 Italy Animal Drugs Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Animal Drugs Sales and Growth Rate (2012-2017)

4 Middle East Animal Drugs (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Animal Drugs Sales and Value (2012-2017)
        4.1.1 Middle East Animal Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Animal Drugs Revenue and Growth Rate (2012-2017)
    4.2 Middle East Animal Drugs Sales and Market Share by Type
    4.3 Middle East Animal Drugs Sales and Market Share by Application
    4.4 Middle East Animal Drugs Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Animal Drugs Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Animal Drugs Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Animal Drugs Sales and Growth Rate (2012-2017)
        4.4.4 Israel Animal Drugs Sales and Growth Rate (2012-2017)
        4.4.5 UAE Animal Drugs Sales and Growth Rate (2012-2017)
        4.4.6 Iran Animal Drugs Sales and Growth Rate (2012-2017)

5 Africa Animal Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Animal Drugs Sales and Value (2012-2017)
        5.1.1 Africa Animal Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Animal Drugs Revenue and Growth Rate (2012-2017)
    5.2 Africa Animal Drugs Sales and Market Share by Type
    5.3 Africa Animal Drugs Sales and Market Share by Application
    5.4 Africa Animal Drugs Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Animal Drugs Sales Volume by Countries (2012-2017)
        5.4.2 Africa Animal Drugs Revenue by Countries (2012-2017)
        5.4.3 South Africa Animal Drugs Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Animal Drugs Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Animal Drugs Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Animal Drugs Sales and Growth Rate (2012-2017)

6 EMEA Animal Drugs Manufacturers/Players Profiles and Sales Data
    6.1 Zoetis
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Animal Drugs Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Zoetis Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Boehringer Ingelheim
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Animal Drugs Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Boehringer Ingelheim Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Bayer
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Animal Drugs Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Bayer Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Elanco Animal Health
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Animal Drugs Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Elanco Animal Health Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Ceva
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Animal Drugs Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Ceva Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Dechra
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Animal Drugs Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Dechra Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Merck
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Animal Drugs Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Merck Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Virbac
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Animal Drugs Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Virbac Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Vetoquinol
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Animal Drugs Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Vetoquinol Animal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Animal Drugs Manufacturing Cost Analysis
    7.1 Animal Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Animal Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Animal Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Animal Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Animal Drugs Market Forecast (2017-2022)
    11.1 EMEA Animal Drugs Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Animal Drugs Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Animal Drugs Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Animal Drugs Price and Trend Forecast (2017-2022)
    11.2 EMEA Animal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Animal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Animal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Animal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Animal Drugs Sales Forecast by Type (2017-2022)
    11.7 EMEA Animal Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer